Patient Square Capital’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
Other funds holding XENE
ACA
DCM
PCH
Patient Square Capital's XENE Position: Q1 2026 in Review
Patient Square Capital increased its Xenon Pharmaceuticals (XENE) stake by 66% in Q1 2026, buying an estimated $4.17M and bringing the position to 227,000 shares worth $13.2M. The position accounts for 2.34% of the portfolio, ranked #13.
Patient Square Capital first reported a position in XENE in Q4 2025 and has held it in 2 quarters since. 290 funds tracked by Wall St. Rank hold XENE as of Q1 2026.
- Patient Square Capital held 227,000 shares of Xenon Pharmaceuticals worth $13.2M as of Q1 2026.
- Patient Square Capital bought 90,500 Xenon Pharmaceuticals shares in Q1 2026, an estimated $4.17M.
- Xenon Pharmaceuticals made up 2.34% of Patient Square Capital's portfolio in Q1 2026, its #13 holding.
- Patient Square Capital first reported a position in Xenon Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
- 290 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q1 2026.
Based on Patient Square Capital's 13F filing for Q1 2026, filed 15 May 2026.